A A Adetunji1, M A Kuti2, R A Audu3, S A Muyibi1, M Imhansoloeva4, O A Mosuro1, E A Solanke1, O M Akpa4, A E Irabor1, Mma Ladipo1, B Berzins5, K Robertson6, A Ogunniyi7, I F Adewole8, B O Taiwo9. 1. Department of Family Medicine, University College Hospital, Ibadan, Nigeria. 2. Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria. 3. Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria. 4. Department of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Ibadan, Nigeria. 5. Division of Infectious Diseases, Center for Global Health, Northwestern University, Chicago, IL, USA. 6. Department of Neurology, University of North Carolina, Chapel Hill, NC, USA. 7. Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria. 8. Department of Obstetrics and Gynaecology, College of Medicine, University of Ibadan, Ibadan, Nigeria. 9. Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Abstract
OBJECTIVES: HIV rapid antibody tests are widely used in Africa, but dual testing sometimes produces discordant results. It is not clear if discordant rapid HIV tests should always heighten suspicion by frontline health workers that early HIV infection is present. Some studies have reported that discordant rapid tests have value for identifying early HIV infection in high HIV prevalence populations. It is not known if rapid test performance influenced this conclusion, or if this observation will hold true for low HIV prevalence populations. We therefore explored the occurrence of discordant rapid HIV tests in a low-resource community. METHODS: A cross-sectional sample of HIV status-unaware adults with recent exposure to unsafe sex was assessed using a validated risk-based tool (University of North Carolina (UNC)-Malawi Risk Screening Score) for acute HIV infection. Participants received rapid testing with Determine™ HIV 1/2 and Uni-Gold™ HIV assays, plus plasma HIV-1 antigen testing with the COBAS® Ampliprep/COBAS® Taqman® HIV-1 assay, followed by western blot in those with detected HIV-1 antigen. RESULTS: Of 408 participants, 1.0% were confirmed to have established HIV infection. The discordance between rapid tests at initial screening was 2.45 and 2.94% when the two assays were used sequentially and simultaneously, respectively. Discordant rapid tests were strongly associated with risk scores > 2 [odds ratio (OR) 10.88; 95% confidence interval (CI) 2.35-50.43], and with detected HIV-1 RNA (OR 26.06; 95% CI 3.91-173.60). CONCLUSIONS: When the sample occurrence of discordance between the first and second tests is below 5%, discordant rapid tests in an adult with sexual risk behaviour should trigger strong suspicion of early HIV infection in low HIV prevalence populations.
OBJECTIVES: HIV rapid antibody tests are widely used in Africa, but dual testing sometimes produces discordant results. It is not clear if discordant rapid HIV tests should always heighten suspicion by frontline health workers that early HIV infection is present. Some studies have reported that discordant rapid tests have value for identifying early HIV infection in high HIV prevalence populations. It is not known if rapid test performance influenced this conclusion, or if this observation will hold true for low HIV prevalence populations. We therefore explored the occurrence of discordant rapid HIV tests in a low-resource community. METHODS: A cross-sectional sample of HIV status-unaware adults with recent exposure to unsafe sex was assessed using a validated risk-based tool (University of North Carolina (UNC)-Malawi Risk Screening Score) for acute HIV infection. Participants received rapid testing with Determine™ HIV 1/2 and Uni-Gold™ HIV assays, plus plasma HIV-1 antigen testing with the COBAS® Ampliprep/COBAS® Taqman® HIV-1 assay, followed by western blot in those with detected HIV-1 antigen. RESULTS: Of 408 participants, 1.0% were confirmed to have established HIV infection. The discordance between rapid tests at initial screening was 2.45 and 2.94% when the two assays were used sequentially and simultaneously, respectively. Discordant rapid tests were strongly associated with risk scores > 2 [odds ratio (OR) 10.88; 95% confidence interval (CI) 2.35-50.43], and with detected HIV-1 RNA (OR 26.06; 95% CI 3.91-173.60). CONCLUSIONS: When the sample occurrence of discordance between the first and second tests is below 5%, discordant rapid tests in an adult with sexual risk behaviour should trigger strong suspicion of early HIV infection in low HIV prevalence populations.
Authors: Susan A Fiscus; Christopher D Pilcher; William C Miller; Kimberly A Powers; Irving F Hoffman; Matthew Price; David A Chilongozi; Clement Mapanje; Robert Krysiak; Syze Gama; Francis E A Martinson; Myron S Cohen Journal: J Infect Dis Date: 2006-12-22 Impact factor: 5.226
Authors: Anne F Gasasira; Grant Dorsey; Moses R Kamya; Diane Havlir; Moses Kiggundu; Philip J Rosenthal; Edwin D Charlebois Journal: J Clin Microbiol Date: 2006-08 Impact factor: 5.948
Authors: Kimberly A Powers; William C Miller; Christopher D Pilcher; Clement Mapanje; Francis E A Martinson; Susan A Fiscus; David A Chilongozi; David Namakhwa; Matthew A Price; Shannon R Galvin; Irving F Hoffman; Myron S Cohen Journal: AIDS Date: 2007-10-18 Impact factor: 4.177
Authors: S M Owen; C Yang; T Spira; C Y Ou; C P Pau; B S Parekh; D Candal; D Kuehl; M S Kennedy; D Rudolph; W Luo; N Delatorre; S Masciotra; M L Kalish; F Cowart; T Barnett; R Lal; J S McDougal Journal: J Clin Microbiol Date: 2008-03-05 Impact factor: 5.948
Authors: Steven Baveewo; Moses R Kamya; Harriet Mayanja-Kizza; Robin Fatch; David R Bangsberg; Thomas Coates; Judith A Hahn; Rhoda K Wanyenze Journal: BMC Res Notes Date: 2012-03-19